|
1
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fagioli F, Biasin E, Mereuta OM, Muraro M,
Luksch R, Ferrari S, Aglietta M and Madon E: Poor prognosis
osteosarcoma: New therapeutic approach. Bone Marrow Transplant.
41:(Suppl 2). S131–S134. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fletcher CDM, Unni KK and Mertens F:
Conventional osteosarcomaWorld Health Organization Classification
of Tumours - Pathology and Genetics of Tumors of Soft Tissue and
Bone. 4th. IARC Press; Lyon: pp. 192013
|
|
4
|
Chou AJ and Gorlick R: Chemotherapy
resistance in osteosarcoma: Current challenges and future
directions. Expert Rev Anticancer Ther. 6:1075–1085. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yao C, Wei JJ, Wang ZY, Ding HM, Li D, Yan
SC, Yang YJ and Gu ZP: Perifosine induces cell apoptosis in human
osteosarcoma cells: New implication for osteosarcoma therapy? Cell
Biochem Biophys. 65:217–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poletajew S, Fus L and Wasiutyński A:
Current concepts on pathogenesis and biology of metastatic
osteosarcoma tumors. Ortop Traumatol Rehabil. 13:537–545. 2011.(In
English, Polish). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu F, Wang W, Zhou HC and Shang XF: High
expression of periostin is dramatically associated with metastatic
potential and poor prognosis of patients with osteosarcoma. World J
Surg Oncol. 12:2872014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nada OH, Ahmed NS and Gabal Abou HH:
Prognostic significance of HLA EMR8-5 immunohistochemically
analyzed expression in osteosarcoma. Diagn Pathol. 9:722014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar JP: The sine oculis homeobox (SIX)
family of transcription factors as regulators of development and
disease. Cell Mol Life Sci. 66:565–583. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anderson AM, Weasner BM, Weasner BP and
Kumar JP: Dual transcriptional activities of SIX proteins define
their roles in normal and ectopic eye development. Development.
139:991–1000. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu PX, Zheng W, Huang L, Maire P, Laclef C
and Silvius D: Six1 is required for the early organogenesis of
mammalian kidney. Development. 130:3085–3094. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Laclef C, Souil E, Demignon J and Maire P:
Thymus, kidney and craniofacial abnormalities in Six 1 deficient
mice. Mech Dev. 120:669–679. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Konishi Y, Ikeda K, Iwakura Y and Kawakami
K: Six1 and Six4 promote survival of sensory neurons during early
trigeminal gangliogenesis. Brain Res. 1116:93–102. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reichenberger KJ, Coletta RD, Schulte AP,
Varella-Garcia M and Ford HL: Gene amplification is a mechanism of
Six1 overexpression in breast cancer. Cancer Res. 65:2668–2675.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Behbakht K, Qamar L, Aldridge CS, Coletta
RD, Davidson SA, Thorburn A and Ford HL: Six1 overexpression in
ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and
is associated with poor survival. Cancer Res. 67:3036–3042. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Imam JS, Buddavarapu K, Lee-Chang JS,
Ganapathy S, Camosy C, Chen Y and Rao MK: MicroRNA-185 suppresses
tumor growth and progression by targeting the Six1 oncogene in
human cancers. Oncogene. 29:4971–4979. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan J, Zhang C and Qian J: Expression and
significance of Six1 and Ezrin in cervical cancer tissue. Tumour
Biol. 32:1241–1247. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng XH, Liang PH, Guo JX, Zheng YR, Han
J, Yu LL, Zhou YG and Li L: Expression and clinical implications of
homeobox gene Six1 in cervical cancer cell lines and cervical
epithelial tissues. Int J Gynecol Cancer. 20:1587–1592.
2010.PubMed/NCBI
|
|
19
|
Li CM, Guo M, Borczuk A, Powell CA, Wei M,
Thaker HM, Friedman R, Klein U and Tycko B: Gene expression in
Wilms' tumor mimics the earliest committed stage in the metanephric
mesenchymal-epithelial transition. Am J Pathol. 160:2181–2190.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu Y, Khan J, Khanna C, Helman L, Meltzer
PS and Merlino G: Expression profiling identifies the cytoskeletal
organizer ezrin and the developmental homeoprotein Six-1 as key
metastatic regulators. Nat Med. 10:175–181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ng KT, Man K, Sun CK, Lee TK, Poon RT, Lo
CM and Fan ST: Clinicopathological significance of homeoprotein
Six1 in hepatocellular carcinoma. Br J Cancer. 95:1050–1055. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Coletta RD, Christensen K, Reichenberger
KJ, Lamb J, Micomonaco D, Huang L, Wolf DM, Müller-Tidow C, Golub
TR, Kawakami K and Ford HL: The Six1 homeoprotein stimulates
tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci USA.
101:6478–6483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Coletta RD, Christensen KL, Micalizzi DS,
Jedlicka P, Varella-Garcia M and Ford HL: Six1 overexpression in
mammary cells induces genomic instability and is sufficient for
malignant transformation. Cancer Res. 68:2204–2213. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kundu ZS: Classification, imaging, biopsy
and staging of osteosarcoma. Indian J Orthop. 48:328–346. 2014.
View Article : Google Scholar
|
|
25
|
Zheng W, Huang L, Wei ZB, Silvius D, Tang
B and Xu PX: The role of Six1 in mammalian auditory system
development. Development. 130:3989–4000. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ikeda K, Kageyama R, Suzuki Y and Kawakami
K: Six1 is indispensable for production of functional progenitor
cells during olfactory epithelial development. Int J Dev Biol.
54:1453–1464. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ford HL, Kabingu EN, Bump EA, Mutter GL
and Pardee AB: Abrogation of the G2 cell cycle checkpoint
associated with overexpression of HSIX1: A possible mechanism of
breast carcinogenesis. Proc Natl Acad Sci USA. 95:12608–12613.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Khan J, Bittner ML, Saal LH, Teichmann U,
Azorsa DO, Gooden GC, Pavan WJ, Trent JM and Meltzer PS: cDNA
microarrays detect activation of a myogenic transcription program
by the PAX3-FKHR fusion oncogene. Proc Natl Acad Sci USA.
96:13264–13269. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu Y, Davicioni E, Triche TJ and Merlino
G: The homeoprotein six1 transcriptionally activates multiple
protumorigenic genes but requires ezrin to promote metastasis.
Cancer Res. 66:1982–1989. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ozaki H, Nakamura K, Funahashi J, Ikeda K,
Yamada G, Tokano H, Okamura HO, Kitamura K, Muto S, Kotaki H, et
al: Six1 controls patterning of the mouse otic vesicle.
Development. 131:551–562. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li X, Oghi KA, Zhang J, Krones A, Bush KT,
Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW and Rosenfeld MG:
Eya protein phosphatase activity regulates Six1-Dach-Eya
transcriptional effects in mammalian organogenesis. Nature.
426:247–254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grifone R, Demignon J, Houbron C, Souil E,
Niro C, Seller MJ, Hamard G and Maire P: Six1 and Six4
homeoproteins are required for Pax3 and Mrf expression during
myogenesis in the mouse embryo. Development. 132:2235–2249. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ikeda K, Ookawara S, Sato S, Ando Z,
Kageyama R and Kawakami K: Six1 is essential for early neurogenesis
in the development of olfactory epithelium. Dev Biol. 311:53–68.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Micalizzi DS, Christensen KL, Jedlicka P,
Coletta RD, Barón AE, Harrell JC, Horwitz KB, Billheimer D,
Heichman KA, Welm AL, et al: The Six1 homeoprotein induces human
mammary carcinoma cells to undergo epithelial-mesenchymal
transition and metastasis in mice through increasing TGF-beta
signaling. J Clin Invest. 119:2678–2690. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Micalizzi DS, Wang CA, Farabaugh SM,
Schiemann WP and Ford HL: Homeoprotein Six1 increases TGF-beta type
I receptor and converts TGF-beta signaling from suppressive to
supportive for tumor growth. Cancer Res. 70:10371–10380. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu D, Li L, Zhang XX, Wan DY, Xi BX, Hu
Z, Ding WC, Zhu D, Wang XL, Wang W, et al: SIX1 promotes tumor
lymphangiogenesis by coordinating TGFβ signals that increase
expression of VEGF-C. Cancer Res. 74:5597–5607. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li Z, Tian T, Lv F, Chang Y, Wang X, Zhang
L, Li X, Li L, Ma W, Wu J and Zhang M: Six1 promotes proliferation
of pancreatic cancer cells via upregulation of cyclin D1
expression. PLoS One. 8:e592032013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jin H, Cui M, Kong J, Cui X, Lin Z, Wu Q
and Liu S: Sineoculis homeobox homolog 1 protein is associated with
breast cancer progression and survival outcome. Exp Mol Pathol.
97:247–252. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hua L, Fan L, Aichun W, Yongjin Z,
Qingqing C and Xiaojian W: Inhibition of Six1 promotes apoptosis,
suppresses proliferation, and migration of osteosarcoma cells.
Tumour Biol. 35:1925–1931. 2014. View Article : Google Scholar : PubMed/NCBI
|
